Laura J. Eccles
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Carcinogens and Genotoxicity Assessment
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Treatments and Studies 3
-
- Lung Cancer Treatments and Mutations 5
- Brain Metastases and Treatment 2
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Peter O’Neill (3 shared papers)Martine E. Lomax (3 shared papers)Simon N. Powell (1 shared paper)Andrew Corneliu Bell (1 shared paper)Adam Lee (5 shared papers)Yong Yuan (7 shared papers)N. Varol (5 shared papers)Hervé Menoni (1 shared paper)
- Journals
- Journal of Thoracic Oncology (5 papers)Lung Cancer (2 papers)DNA repair (2 papers)Annals of Oncology (2 papers)Nucleic Acids Research (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Laura J. Eccles
18 papers receiving 841 citations
Laura J. Eccles's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 396
- Cancer Research 123
- Pulmonary and Respiratory Medicine 266
- Molecular Biology 256
- Radiology, Nuclear Medicine and Imaging 72
Countries citing papers authored by Laura J. Eccles
This map shows the geographic impact of Laura J. Eccles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura J. Eccles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura J. Eccles more than expected).
Fields of papers citing papers by Laura J. Eccles
This network shows the impact of papers produced by Laura J. Eccles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura J. Eccles. The network helps show where Laura J. Eccles may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura J. Eccles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227 Hit paper breakdown → | 2022 | 299 |
| 2 | 2010 | 205 | |
| 3 | 2022 | 78 | |
| 4 | 2009 | 64 | |
| 5 | 2023 | 58 | |
| 6 | 2024 | 41 | |
| 7 | 2023 | 23 | |
| 8 | 2018 | 22 | |
| 9 | 2015 | 20 | |
| 10 | 2023 | 15 | |
| 11 | 2021 | 9 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2025 | 3 | |
| 15 | 2025 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2021 | 1 |
About Laura J. Eccles
Laura J. Eccles is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Genetics, having authored 18 papers that have together received 857 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (5 papers), DNA Repair Mechanisms (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Brain Metastases and Treatment (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (396 citations), Cancer Research (123 citations), Pulmonary and Respiratory Medicine (266 citations), Molecular Biology (256 citations) and Radiology, Nuclear Medicine and Imaging (72 citations). Laura J. Eccles has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Peter O’Neill, Martine E. Lomax, Simon N. Powell, Andrew Corneliu Bell, Adam Lee, Yong Yuan, N. Varol, Hervé Menoni, Dimitar Angelov and Sarah M. Goring. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, DNA repair, Annals of Oncology and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.